Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| IONS | CLUSTER | neutral | 3/10 | Two Ionis Pharmaceuticals executives, including the Chief Business Officer and EVP of Corporate and Development Operatio | Apr 17, 2026 |
| SDGR | CLUSTER | bearish | 6/10 | Schrodinger CEO Farid Ramy sold $530,233 worth of shares in an open-market transaction on April 16, 2026, following deri | Apr 17, 2026 |
| UTHR | CLUSTER | neutral | 3/10 | Three United Therapeutics executives, including the CEO, CFO, and General Counsel, conducted open-market share sales tot | Apr 17, 2026 |
| WHWK | CLUSTER | bearish | 7/10 | Three corporate insiders at Whitehawk Therapeutics, including the CEO and CFO, sold shares in a coordinated 7-day window | Apr 17, 2026 |
| PCSA | CLUSTER | bullish | 5/10 | Two corporate insiders at Processa Pharmaceuticals, the CFO and Chief Development Officer, made open-market purchases to | Apr 17, 2026 |
| MPLT | CLUSTER | bearish | 6/10 | Multiple executives at MapLight Therapeutics, including CEO Christopher Kroeger and CFO Vishwas Setia, sold shares in a | Apr 17, 2026 |
| LQDA | CLUSTER | bearish | 7/10 | Eight insiders at Liquidia Corp, including CEO Roger Jeffs and CFO Michael Kaseta, sold shares in a concentrated 7-day w | Apr 16, 2026 |
| ADPT | CLUSTER | bearish | 7/10 | Adaptive Biotechnologies (ADPT) saw significant insider selling over a 7-day window, led by CEO Chad Robins and COO Juli | Apr 16, 2026 |
| TOI | CLUSTER | mixed | 5/10 | Two insiders traded TOI shares over the past week, including a $201K sale by Director Kaushal Mohit and a $62K purchase | Apr 16, 2026 |
| SION | CLUSTER | bearish | 7/10 | Two directors, ORBIMED ADVISORS LLC and Thompson Peter A., each sold approximately 235,900 shares of Sionna Therapeutics | Apr 16, 2026 |
| GILD | CLUSTER | bearish | 6/10 | Two Gilead Sciences executives, the CFO and Chief Communications Officer, each sold 3,000 shares in open-market transact | Apr 16, 2026 |
| KYMR | CLUSTER | neutral | 3/10 | Two corporate insiders at Kymera Therapeutics sold shares in the past week, including Director Booth Bruce selling 4,159 | Apr 16, 2026 |
| UTHR | CLUSTER | neutral | 3/10 | Three United Therapeutics insiders, including the CEO and CFO, conducted open-market share sales totaling $158K over a 7 | Apr 16, 2026 |
| TVTX | CLUSTER | bearish | 7/10 | Four executives at Travere Therapeutics sold $2.15M in shares over two days, including significant sales by the Chief Le | Apr 16, 2026 |
| TVTX | CLUSTER | bearish | 7/10 | Travere Therapeutics insiders executed a significant cluster of open-market sales totaling $2.1 million over seven days, | Apr 15, 2026 |
| MLYS | CLUSTER | bearish | 7/10 | Two top executives at Mineralys Therapeutics, the CEO and Chief Medical Officer, sold shares in a concentrated 7-day win | Apr 15, 2026 |
| WHWK | CLUSTER | bearish | 6/10 | Two corporate insiders at Whitehawk Therapeutics, including CEO David James Lennon, sold shares in open-market transacti | Apr 15, 2026 |
| CYTK | CLUSTER | bearish | 7/10 | Two top executives at Cytokinetics, including the CEO and Chief Commercial Officer, sold nearly $1 million in shares ove | Apr 15, 2026 |
| IRON | CLUSTER | bearish | 7/10 | Two C-suite executives at Disc Medicine, Inc. (IRON) sold shares worth $694K in the past week, including CFO Jean M. Fra | Apr 15, 2026 |
| CGEN | CLUSTER | neutral | 2/10 | Two corporate insiders at Compugen Ltd, CEO Ophir Eran and SVP Levine Zurit, sold shares in open-market transactions tot | Apr 15, 2026 |
| GLUE | CLUSTER | neutral | 3/10 | Two C-suite executives at Monte Rosa Therapeutics sold shares in the past week, including CEO Markus Warmuth selling $14 | Apr 15, 2026 |
| FTLF | CLUSTER | neutral | 4/10 | Two non-executive directors at FitLife Brands collectively purchased $59,220 worth of shares in open-market transactions | Apr 14, 2026 |
| WHWK | CLUSTER | bearish | 7/10 | Whitehawk Therapeutics CEO David James and insider Bryan Ball collectively sold $228,000 worth of shares in open-market | Apr 13, 2026 |
| ADPT | CLUSTER | neutral | 4/10 | Four corporate insiders at Adaptive Biotechnologies (ADPT) sold shares in a concentrated 7-day window, including CEO Cha | Apr 13, 2026 |
| NTHI | CLUSTER | neutral | 3/10 | Two corporate insiders at NEONC Technologies Holdings (NTHI) purchased shares in open-market transactions totaling $28K | Apr 13, 2026 |
| LQDA | CLUSTER | bearish | 6/10 | Liquidia Corp CFO and CEO sold shares in a coordinated 7-day window, with total open-market proceeds of $6.39 million. T | Apr 13, 2026 |
| UTHR | CLUSTER | neutral | 3/10 | CEO Martine Rothblatt and CFO James Edgemond each conducted open-market share sales totaling $573K in the past week, fol | Apr 13, 2026 |
| KNSA | CLUSTER | bearish | 6/10 | Three corporate insiders at Kiniksa Pharmaceuticals sold shares in open-market transactions totaling $789K over a 7-day | Apr 13, 2026 |
| NUVL | CLUSTER | bearish | 6/10 | Nuvalent CEO and Chief Scientific Officer sold shares worth $1.4M in the past week, including a $1.17M open-market sale | Apr 13, 2026 |
| BLTE | CLUSTER | bearish | 6/10 | Two C-suite executives at Belite Bio sold shares in a coordinated 7-day window, totaling $812K in open-market transactio | Apr 13, 2026 |